Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three NDAs. There are three patents protecting this compound.
This ingredient has four patent family members in four countries.
Three suppliers are listed for this compound. There are twelve tentative approvals for this compound.
Copyright © DrugPatentWatch. Originally published at New tentative approval for Hospira Inc drug bortezomib